Investigational chimp adenovirus MERS-CoV vaccine protects monkeys

Published on April 20, 2020

An investigational vaccine called ChAdOx1 MERS protected two groups of rhesus macaques from disease caused by Middle East respiratory syndrome coronavirus (MERS-CoV). ChAdOx1 MERS, which uses a replication-deficient chimpanzee adenovirus to deliver a MERS-CoV protein in recipients, also worked against six different strains of MERS-CoV when tested in mice as a single vaccination. NIH

Other news

WHO launches a chatbot on Facebook Messenger to combat COVID-19 misinformation

April 20, 2020
In an effort to better inform the world about CODIV-19, the WHO has launched a Facebook Messenger version of its WHO Health Alert platform – offering instant and accurate information about COVID-19– via Facebook’s global reach. WHO

EARLY RELEASE: Cleaning and Disinfectant Chemical Exposures and Temporal Associations with COVID-19 --- National Poison Data System, United States, January 1, 2020--March 31, 2020

April 20, 2020
Exposures to cleaners and disinfectants reported to the National Poison Data System, a surveillance system of poison center calls, increased substantially beginning in March 2020.